A Study to Evaluate the Food-Effect of H3B-6527

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

December 27, 2017

Primary Completion Date

January 27, 2018

Study Completion Date

January 27, 2018

Conditions
Healthy Participants
Interventions
DRUG

H3B-6527

Oral capsule

Trial Locations (1)

78217

Worldwide Clinical Trials, San Antonio

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

H3 Biomedicine Inc.

INDUSTRY

lead

Eisai Inc.

INDUSTRY